Starsource Multitrade — 360° view

Starsource Multitrade, a company in the Pharmaceuticals industry, reported revenue of ₹0.07 crore and net profit of ₹0.02 crore for the June 2026 quarter.

Starsource Multitrade (BSE: STARSOURCE) closed at ₹95.95 on 19 Nov 2026, down 14.1% over the past year. Its market capitalisation is ₹14 crore.

Share price
₹95.95 (19 Nov 2026)
Market cap
₹14 Cr (19 Nov 2026)
Revenue
₹0 Cr (June 2026 quarter)
Net profit
₹0 Cr (June 2026 quarter)
ROCE
0.28% (FY26)
ROE
0.28% (FY26)
Book value
₹8.33 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹152.90 / ₹70.01 (19 Nov 2026)
1-year return
-14.1% (to 19 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: STARSOURCE

The Chemo Pharma Laboratories Limited was established in 1942 and was making Pharmaceuticals and bulk drugs. However due to increased competition, Company disposed the business. Company is in advanced stage of negotiation to diversify and take over a sick company

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.